128 related articles for article (PubMed ID: 22343682)
1. Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
Yuana Y; Osanto S; Bertina RM
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):244-50. PubMed ID: 22343682
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
4. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
Basavaraj MG; Olsen JO; Østerud B; Hansen JB
Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024
[TBL] [Abstract][Full Text] [Related]
5. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
6. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
Christersson C; Lindahl B; Siegbahn A
Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
[TBL] [Abstract][Full Text] [Related]
7. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay.
Hellum M; Øvstebø R; Trøseid AM; Berg JP; Brandtzaeg P; Henriksson CE
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):520-6. PubMed ID: 22732249
[TBL] [Abstract][Full Text] [Related]
8. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
9. Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma.
Michelsen AE; Wergeland R; Stokke O; Brosstad F
Thromb Res; 2006; 117(6):705-11. PubMed ID: 15990159
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor and its measurement in whole blood, plasma, and microparticles.
Key NS; Mackman N
Semin Thromb Hemost; 2010 Nov; 36(8):865-75. PubMed ID: 21049387
[TBL] [Abstract][Full Text] [Related]
11. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.
Helmond SE; Catalfamo JL; Brooks MB
Am J Vet Res; 2013 Feb; 74(2):207-15. PubMed ID: 23363344
[TBL] [Abstract][Full Text] [Related]
13. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
Ye R; Ye C; Huang Y; Liu L; Wang S
Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
[TBL] [Abstract][Full Text] [Related]
14. Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy.
Chung J; Suzuki H; Tabuchi N; Sato K; Shibamiya A; Koyama T
Thromb Haemost; 2007 Aug; 98(2):368-74. PubMed ID: 17721619
[TBL] [Abstract][Full Text] [Related]
15. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
16. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
[TBL] [Abstract][Full Text] [Related]
17. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
[TBL] [Abstract][Full Text] [Related]
18. Evidence for direct transfer of tissue factor from monocytes to platelets in whole blood.
Sovershaev MA; Egorina EM; Osterud B; Hansen JB
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):345-50. PubMed ID: 22343684
[TBL] [Abstract][Full Text] [Related]
19. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]